Detalhe da pesquisa
1.
Sustained S-IgG and S-IgA antibodies to Moderna's mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations.
Front Immunol
; 15: 1348905, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357547
2.
Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy.
Front Immunol
; 14: 1183983, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37205095
3.
Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens.
Front Immunol
; 14: 1148877, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37153598
4.
Spike protein is a key target for stronger and more persistent T-cell responses-a study of mild and asymptomatic SARS-CoV-2 infection.
Int J Infect Dis
; 136: 49-56, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683720
5.
Bacterial microbiome and host inflammatory gene expression in foreskin tissue.
Heliyon
; 9(11): e22145, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38053902
6.
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin.
AIDS
; 37(11): 1651-1659, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37289572
7.
Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial.
EBioMedicine
; 93: 104648, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37327677
8.
Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa.
Front Immunol
; 13: 965214, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35967369
9.
Short-term oral pre-exposure prophylaxis against HIV-1 modulates the transcriptome of foreskin tissue in young men in Africa.
Front Immunol
; 13: 1009978, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36479111
10.
Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay.
Front Immunol
; 13: 1029029, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36532063
11.
Interferon gamma (IFN-γ) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigens.
Vaccine
; 37(1): 113-122, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30459072
12.
Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles.
Vaccine
; 33(14): 1664-72, 2015 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25728323
13.
Profile of T cell recognition of HIV type 1 consensus group M Gag and Nef peptides in a clade A1- and D-infected Ugandan population.
AIDS Res Hum Retroviruses
; 28(4): 384-92, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21867408
14.
Coreceptor and cytokine concentrations may not explain differences in disease progression observed in HIV-1 clade A and D infected Ugandans.
PLoS One
; 6(5): e19902, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21655330
15.
CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/µL: The DART Trial STI Substudy.
AIDS Res Treat
; 2011: 875028, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21490785